You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
11 April 2022
GlaxoSmithKline (GSK) Consumer Healthcare is considering a licensing deal for Cann Group’s cannabidiol (CBD) capsule in Australia and other markets worldwide.
4 March 2021
2020 was a challenging year for consumer healthcare companies seeking to introduce new products, says IQVIA Consumer Health’s Amit Shukla, who points out there were fewer launches and they were backed by lower marketing spends. Two areas attracting significant interest during the year, says Shukla,...
5 February 2021
A bipartisan bill that would allow hemp-derived cannabidiol (CBD) products to be marketed legally as dietary supplements has been reintroduced in the US.
23 December 2020
The US Food and Drug Administration (FDA) has issued a number of warning letters to cannabidiol (CBD) companies, the Norwegian Medicines Agency (NoMA) is expanding the list of general-sale medicines, and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued an exceptional us...
16 December 2020
Australia’s Therapeutic Goods Administration (TGA) has now given the final go-ahead for certain low-dose cannabidiol (CBD) medicines to be sold without a prescription. However, the TGA has made a number of changes to its interim decision released in September 2020.
15 December 2020
Nestlé has launched a functional food in China that supports mobility during ageing, The Nature’s Bounty Co has expanded its immune support portfolio in the US, and The Vitamin Shoppe is stocking the full line of Martha Stewart CBD products.